M. W. van den Heuvel

发表

Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.

M. W. van den Heuvel, Antoinetta Jacoba Maria van Bragt, Ali Kafi Mohammed Alnabawy, 2005, Contraception.

Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade.

T. Kerbusch, M. W. van den Heuvel, H. Kleijn, 2011, British journal of clinical pharmacology.

Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices.

J. Necciari, F. Paolucci, T. van Dinther, 2003, Clinical laboratory.

Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study.

J. Driessen, M. W. van den Heuvel, J. Hunter, 2010, British journal of anaesthesia.

Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.

M. Hollmann, M. W. van den Heuvel, N. Harper, 2015, British journal of anaesthesia.

Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers: a modelling-based pilot study.

L. Foubert, P. De Kam, M. W. van den Heuvel, 2010, British journal of anaesthesia.

Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study.

M. W. van den Heuvel, J. Smeets, Thijs MP van Iersel, 2010, Clinical drug investigation.

Dialysability of sugammadex and its complex with rocuronium in intensive care patients with severe renal impairment.

M. C. V. D. Heuvel, S. Eloot, M. W. van den Heuvel, 2012, British journal of anaesthesia.

Effect of Sugammadex on QT/QTc Interval Prolongation when Combined with QTc-Prolonging Sevoflurane or Propofol Anaesthesia

P. De Kam, S. Ramael, M. W. van den Heuvel, 2013, Clinical Drug Investigation.

Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.

M. W. van den Heuvel, J. Smeets, Alexandra J. M. Zwiers, 2011, Clinical drug investigation.

Pharmacokinetics of sugammadex 16 mg/kg in healthy Chinese volunteers.

Zaiqi Wang, P. De Kam, M. W. van den Heuvel, 2015, International journal of clinical pharmacology and therapeutics.

Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.

Filippos Kesisoglou, Shaun Fitzpatrick, S. Fitzpatrick, 2014, Journal of pharmaceutical sciences.

Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE).

A. Cohen, E. Uchida, S. D. de Visser, 2003, Contraception.

Using mechanistic models to support development of complex generic drug products: European Medicines Agency perspective

Flora Musuamba Tshinanu, E. Manolis, A. Lindahl, 2023, CPT: pharmacometrics & systems pharmacology.

Commentary on the MID3 Good Practices Paper

Aris Dokoumetzidis, Norbert Benda, Wei Zhao, 2017, CPT: pharmacometrics & systems pharmacology.